DE60021583D1 - Arzneimittel für die verhinderung und/oder behandlung von kardialen durchblutungsstörungen, peripheren gefässkrankheiten, tumoren und wunden - Google Patents
Arzneimittel für die verhinderung und/oder behandlung von kardialen durchblutungsstörungen, peripheren gefässkrankheiten, tumoren und wundenInfo
- Publication number
- DE60021583D1 DE60021583D1 DE60021583T DE60021583T DE60021583D1 DE 60021583 D1 DE60021583 D1 DE 60021583D1 DE 60021583 T DE60021583 T DE 60021583T DE 60021583 T DE60021583 T DE 60021583T DE 60021583 D1 DE60021583 D1 DE 60021583D1
- Authority
- DE
- Germany
- Prior art keywords
- diseases
- peripheral vascular
- cardial
- wounds
- bleaching
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5064—Endothelial cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99870171A EP1076091A1 (de) | 1999-08-09 | 1999-08-09 | Arzneimittel für die Verhinderung und/oder Behandlung von Herzischämie, peripheren Gefässkrankheiten, Tumoren und Wunden |
PCT/EP2000/007731 WO2001011038A2 (de) | 1999-08-09 | 2000-08-09 | Use |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60021583D1 true DE60021583D1 (de) | 2005-09-01 |
Family
ID=8243881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60021583T Expired - Fee Related DE60021583D1 (de) | 1999-08-09 | 2000-08-09 | Arzneimittel für die verhinderung und/oder behandlung von kardialen durchblutungsstörungen, peripheren gefässkrankheiten, tumoren und wunden |
Country Status (6)
Country | Link |
---|---|
US (1) | US20020156123A1 (de) |
EP (3) | EP1076091A1 (de) |
AT (1) | ATE300614T1 (de) |
AU (1) | AU6440800A (de) |
DE (1) | DE60021583D1 (de) |
WO (1) | WO2001011038A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001024826A2 (en) * | 1999-10-06 | 2001-04-12 | The Brigham And Women's Hospital, Inc. | Inrease of enos activity through activation of the pi3-kinase/akt pathway by estrogens |
GB2360453B (en) * | 2000-01-05 | 2004-09-01 | Univ Cardiff | Treatment of skin conditions |
US20020077283A1 (en) | 2000-09-08 | 2002-06-20 | Sessa William C. | Caveolin peptides and their use as therapeutics |
AU2002951611A0 (en) * | 2002-09-24 | 2002-10-10 | The Baker Medical Research Institute | Cholesterol efflux and uses thereof |
US8546347B2 (en) * | 2008-03-21 | 2013-10-01 | Seoul National University Industry Foundation | Composition for treatment and improvement of diabetes comprising caveolin as active ingredient and a method for treatment of diabetes using it |
US20150141340A1 (en) * | 2012-06-04 | 2015-05-21 | Yale University | Method of treating and preventing ocular angiogenesis |
KR102588702B1 (ko) | 2013-03-15 | 2023-10-16 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 누트린-3a 및 펩티드에 의한 폐 섬유증의 저해 |
JP7496826B2 (ja) * | 2018-09-10 | 2024-06-07 | ラング セラピューティクス,エルエルシー | Cav-1タンパク質の修飾ペプチドフラグメント及び線維症の治療におけるその使用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0471236T3 (da) * | 1990-07-30 | 1995-07-24 | Takeda Chemical Industries Ltd | Imidazopyridinderivater og deres anvendelse |
FR2722507B1 (fr) * | 1994-07-12 | 1996-08-14 | Rhone Poulenc Rorer Sa | Adenovirus comportant un gene codant pour une no synthase |
JPH1087698A (ja) * | 1996-07-09 | 1998-04-07 | Takeda Chem Ind Ltd | 新規タンパク質およびそのdna |
WO1998048826A1 (en) * | 1997-04-30 | 1998-11-05 | Northwestern University | Inhibition of nitric oxide synthase by amino acids and dipeptides |
YU2700A (sh) * | 1997-08-29 | 2002-06-19 | Pfizer Products Inc. | Farmaceutska kombinacija koja obuhvata amlodipin i statin jedinjenja |
US6007821A (en) * | 1997-10-16 | 1999-12-28 | Fordham University | Method and compositions for the treatment of autoimmune disease using heat shock proteins |
AU734476B2 (en) * | 1997-11-05 | 2001-06-14 | Baylor College Of Medicine | Sequences for targeting metastatic cells |
IL134364A0 (en) * | 1997-12-12 | 2001-04-30 | Warner Lambert Co | ANTIHYPERLIPIDEMIC STATIN-LP (a) INHIBITOR COMBINATIONS |
US6261760B1 (en) * | 1998-03-09 | 2001-07-17 | The Regents Of The University Of California | Regulation of the cell cycle by sterols |
AU4988100A (en) * | 1999-05-07 | 2000-11-21 | Brigham And Women's Hospital | Use of hmgcoa reductase inhibitors in the prevention of diseases whose pathogenesis is dependent on neovascularization |
-
1999
- 1999-08-09 EP EP99870171A patent/EP1076091A1/de not_active Withdrawn
-
2000
- 2000-08-09 WO PCT/EP2000/007731 patent/WO2001011038A2/de active Search and Examination
- 2000-08-09 EP EP05012435A patent/EP1586644A3/de not_active Withdrawn
- 2000-08-09 AU AU64408/00A patent/AU6440800A/en not_active Abandoned
- 2000-08-09 AT AT00951488T patent/ATE300614T1/de not_active IP Right Cessation
- 2000-08-09 DE DE60021583T patent/DE60021583D1/de not_active Expired - Fee Related
- 2000-08-09 EP EP00951488A patent/EP1206539B1/de not_active Expired - Lifetime
-
2002
- 2002-02-11 US US10/068,965 patent/US20020156123A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1586644A2 (de) | 2005-10-19 |
AU6440800A (en) | 2001-03-05 |
EP1206539B1 (de) | 2005-07-27 |
EP1076091A1 (de) | 2001-02-14 |
WO2001011038A3 (de) | 2001-12-13 |
WO2001011038A2 (de) | 2001-02-15 |
EP1586644A3 (de) | 2008-06-25 |
ATE300614T1 (de) | 2005-08-15 |
EP1206539A2 (de) | 2002-05-22 |
US20020156123A1 (en) | 2002-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE339187T1 (de) | Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt | |
BR0209523A (pt) | Utilização de um antioxidante para a fabricação de um medicamento destinado ao tratamento e/ou à prevenção dos distúrbios oculares de superfìcie | |
ES2054995T3 (es) | Nuevos derivados del acido benzoico y acido fenilacetico, su obtencion y empleo como medicamentos. | |
IS6647A (is) | Kínasólínafleiður til að meðhöndla æxli | |
DE3382641D1 (de) | Arzneimittel fuer die therapeutische behandlung von alopezie. | |
DE69634556D1 (de) | L-Carnitin oder ihre Derivate und Resveratrol oder ihre Derivate zur Vorbeugung und Behandlung von kardiovaskulären Erkrankungen, peripheren Gefässkrankheit, peripheren diabetischen Neuropathie und diese enthaltende pharmazeutische Zusammensetzungen | |
DE69715439D1 (de) | Pyridylalkan-säureamide als cytostatika und immunosupressive arzneimittel | |
ATE203403T1 (de) | Verwendung von prolin als einziger therapeutischer wirkstoff zur herstellung eines arzneimittels zur behandlung von rheumatischen erkrankungen und von chronischen und traumatisch bedingten schmerzzuständen | |
ATE145136T1 (de) | Verwendung von ketoconazol und ein retinoid zur behandlung der akne vulgaris | |
FR2755965B1 (fr) | Composes biaromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations | |
ATE231852T1 (de) | Bicyclische aromatische verbindungen | |
DE59508961D1 (de) | Verwendung von weihrauch zur behandlung der alzheimer-krankheit | |
DE69713620D1 (de) | Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia | |
NZ328874A (en) | Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders | |
DE60021583D1 (de) | Arzneimittel für die verhinderung und/oder behandlung von kardialen durchblutungsstörungen, peripheren gefässkrankheiten, tumoren und wunden | |
BR9910899A (pt) | Compostos de ácido sulfÈnico ou sulfonilamino n-(hetero-aralquil)-azaeterocicliamida | |
MX9501849A (es) | Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos. | |
ATE340561T1 (de) | Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen | |
ATE309817T1 (de) | Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs | |
DE69917074D1 (de) | Optisch aktives pyridyl-4h-1,2,4-oxadiazinderivat und seine verwendung zur behandlung von gefässkrankheiten | |
WO1999050239A3 (fr) | Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant | |
ATE331523T1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
RU2144834C1 (ru) | Бумажный санитарно-гигиенический материал | |
RU95101840A (ru) | Сложные эфиры циклогексанола и содержащий их фармацевтический препарат | |
RU2248202C2 (ru) | Противогрибковый препарат |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |